ClariMed Inc. Launches State-of-the-Art Research Facility in the UK
In a significant leap forward for medical device research, ClariMed Inc. has officially opened its latest advanced facility in Cambridge, UK, aimed at enhancing human factors research. Situated just a short distance from London and easily accessible from Stansted Airport, this facility is expected to significantly bolster ClariMed's capacity to conduct advanced usability studies for human-centered medical devices.
Innovative Design Enhancements
The newly constructed facility incorporates cutting-edge design elements that prioritize the quality and scope of human factors studies. A noteworthy feature of the facility is a dedicated observation area located on the second floor, which allows for unparalleled visibility into participant interactions during studies. This setup enables clients and researchers to observe the studies with minimal interference, thereby promoting more natural user behaviors and yielding more accurate research results.
Julian Dixon, Associate Director of Human Factors and Site Lead in the Cambridge office, remarked, "This facility marks a major enhancement in our ability to conduct sophisticated usability studies. The elevated observation area provides our clients with unprecedented visibility into user interactions, while our improved recording capabilities and flexible study spaces allow for exceptional fidelity in simulating various usage environments."
Key Features of the Facility
The Cambridge facility is equipped with several important features, including:
- - Multi-angle recording capabilities for comprehensive interaction analysis.
- - Flexible study spaces that can simulate different healthcare environments.
- - Dedicated surgical simulation rooms.
- - A specialized room for reprocessing tasks.
- - An operational ambulance for realistic field studies.
- - Advanced observation suite with real-time data collection capabilities.
- - Sophisticated environmental controls for precise testing conditions.
This strategic location not only enables access to a diverse participant pool throughout the UK but also facilitates international clients and study participants’ visits due to its proximity to key transportation hubs.
Strategic Expansion and Commitment
Kelley Kendle, CEO of ClariMed, emphasized the strategic importance of this new facility: "This investment greatly enhances our ability to serve international clients with increasingly complex research needs. The advanced capabilities of our new facility will enable us to conduct more sophisticated studies, ultimately leading to the development of safer and more effective medical devices."
The facility is designed to support a wide range of human factors studies, from early concept testing to validation studies. Its adaptable configuration allows for the evaluation of all types of medical devices, from wearable technology to surgical robots, including specialized areas for in-home simulation and professional healthcare settings.
Jessica Köhne, Senior Human Factors Consultant and Site Lead in Leeds, stated, "The adaptability of our new space allows us to recreate authentic usage scenarios across various healthcare environments. This capability is invaluable for understanding how medical devices perform under real-world conditions, helping our clients to optimize their products for safe and effective usage across different environments and user groups."
This latest development builds on ClariMed's recent growth in the UK market, including the opening of its Leeds office, and reinforces the company's commitment to delivering comprehensive human factors engineering services to the global medical device industry.
About ClariMed
ClariMed is a human-centered development and regulatory consulting firm for medical products created by pharmaceutical and medical device manufacturers. Our professional services foster innovation while ensuring the safe and effective use of medical products. For more information, visit
www.clarimed.com. For inquiries, please contact [email protected].